Synovasure® Alpha Defensin Test
Introducing Synovasure Alpha Defensin Test for Joint Infection
The Synovasure Alpha Defensin Test is the first and only test specifically designed and validated for the diagnosis of Joint Infection. Developed to deliver accuracy, performance and ease of use.
Unparalleled Accuracy
Performance backed by data
In the 149 patient study1, the Synovasure Alpha Defensin Test maintained its performance in typically challenging situations such as:
14 of 38 patients with PJI were culture negative and the Synovasure Alpha Defensin Test correctly identified all 14 as infected
Synovasure Alpha Defensin Test studies included patients with systemic inflammatory disease and its performance was maintained in this population
27% of patients with PJI had been treated with antibiotics prior to aspiration and the Synovasure Alpha Defensin Test was not adversely affected in this population.